ReviewJournal of diabetes research2015

The Place of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Therapeutics: A "Me Too" or "the Special One" Antidiabetic Class?

Ricardo Godinho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.